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ABSTRACT 
Extracellular superoxide dismutase (SOD3), a secretory copper enzyme, plays an important role 
in atherosclerosis and hypertension by modulating the levels of extracellular superoxide anion 
(O2•–) in the vasculature. Little is known about the mechanisms by which SOD3 obtains its 
catalytic copper cofactor. Menkes ATPase (MNK) has been shown to transport cytosolic copper 
to the secretory pathway in nonvascular cells. We performed the present study to determine 
whether MNK is required for the activation of SOD3 in the vasculature. Here we show that 
MNK was highly expressed in the various vascular tissues and cells. Aortas and cultured 
fibroblasts from MNK mutant (MNKmut) mice showed a marked decrease in specific activity of 
SOD3, but not SOD1 (cytosolic form), which was partially restored by copper addition. Copper 
treatment in wild-type cells promoted the direct interaction and colocalization of SOD3 with 
MNK in the trans-Golgi network (TGN), suggesting that MNK transports copper to SOD3 in the 
TGN. Aortas of MNKmut mice revealed a decrease in activity of SOD3, but not SOD1, in 
association with a robust increase in O2•– levels. Finally, both MNK and SOD3 proteins were 
highly expressed in the intimal lesions of atherosclerotic vessels. In conclusion, vascular MNK 
plays an essential role in full activity of SOD3 through transporting copper to SOD3 in the TGN, 
thereby regulating O2•– levels in the vasculature. These studies provide a novel insight into 
vascular MNK as a critical modulator of “superoxide” stress, which may contribute to 
cardiovascular disease. 
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ascular superoxide anion (O2•–) production contributes to the pathogenesis of many 
cardiovascular diseases, including atherosclerosis, hypertension, and diabetes (1, 2). The 
major cellular defense against O2•– is a group of oxidoreductases known as superoxide 
dismutases (SODs). In mammalian tissue, three isoforms of SODs exist: the cytoplasmic 
Cu/Zn SOD (SOD1), the mitochondrial Mn SOD (SOD2), and the extracellular SOD (SOD3). 
SOD3 is highly expressed in the vasculature, which is synthesized by vascular smooth muscle 
cells and fibroblasts, and is the major SOD in the extracellular space (3). It is secreted and 
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anchored to the extracellular matrix and endothelial cell surface through binding to the heparan 
sulfate proteoglycan, collagen, and fibulin-5 (3–5). Because of its extracellular location, SOD3 
plays an important role in regulating blood pressure and endothelial function by modulating the 
levels of extracellular O2•– and nitric oxide bioactivity in the vasculature (3, 6, 7). Recently, the 
R213G polymorphism in the SOD3 gene, which reduces binding to endothelial surface and 
increases serum SOD3 levels, has been linked to an increase in cardiovascular risk (8). 
SOD3 is a secretory copper-containing enzyme with a similar active site to that of the SOD1. It 
has been shown that the SOD activity of both wild-type SOD1 and SOD3 depends critically on 
the presence of the copper ion at its native metal binding sites (9–11). Indeed, the mechanism of 
scavenging O2•– by SOD involves alternate reduction and reoxidation of the copper ion at the 
active site of the enzyme. Under physiological conditions, the level of intracellular free copper is 
extraordinarily restricted (12). Thus, SOD1 obtains its catalytic copper ion through interaction 
with the cytosolic carrier protein CCS (copper chaperone for SOD1) (13, 14). In contrast, the 
cytosolic copper chaperone Atox1, not CCS, is required for full activation of SOD3 (11). Note 
that SOD3 secretes through endoplasmic reticulum-Golgi pathway where Atox1 does not exist. 
Thus, the cytosolic Atox1 itself is required, but not sufficient for delivering copper to SOD3 
protein to regulate its full activity. 
Menkes ATPase (ATP7A, MNK) plays a key role in copper transport from the cytosol into the 
secretory pathways (15, 16). A loss-of-function X-linked mutation of MNK leads to Menkes 
disease, a disorder characterized by the marked decrease in copper levels in most tissues except 
for the kidney and small intestine. Menkes patients show multiple abnormalities secondary to 
deficiencies in the activity of some secretory copper enzymes, such as dopamine β-
monooxygenase (neurological abnormalities), tyrosinase (hypopigmentation), and lysyl oxidase 
(vascular abnormalities and connective tissue abnormalities), leading to death in infancy (16). 
Importantly, immunocytochemical studies in cultured cells demonstrated that under normal 
concentration of copper, MNK is localized to the trans-Golgi network, where MNK delivers 
copper to some secretory copper enzymes (17, 18). However, there is no information regarding 
whether MNK is required for delivering copper to SOD3. 
In the current study, using two different MNK mutant mice with reduced copper transport 
function (19–25), we provide the first evidence that MNK is highly expressed in the vasculature 
and that MNK is required for full activation of vascular SOD3 by transporting copper to SOD3 
in the trans-Golgi network, thereby regulating O2•– levels in the vasculature. Of note, the copper 
transport to SOD3 by MNK is mediated through direct protein-protein interaction. Moreover, 
both MNK and SOD3 proteins are highly expressed in the intimal lesions of atherosclerotic 
vessels. These studies provide a novel insight into vascular MNK as a critical modulator of 
“superoxide” stress, which may contribute to cardiovascular disease. 
MATERIALS AND METHODS 
Materials, animals, and cell culture 
All reagents were purchased from Sigma (St. Louis, MO), except when specified. The fibroblasts 
derived from male brindled MNK mutant mice, the corresponding wild-type cells (21–23), and 
antibody against the peptides 1445-1465 (SEPDKHSLLYGDFREDDDTTL) of murine MNK 
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(26) are a kind gift from Dr. Jonathan Gitlin (Washington University School of Medicine, St. 
Louis, MO). The specificity of this murine Menkes ATPase antibody was confirmed by Western 
analysis and immunofluorescence showing a significant decrease in the immunofluorescence 
signal in MNK mutant cells despite normal integrity of the Golgi, as revealed by GS28 staining 
(26). The human MNK cDNA in pWSK29 was a kind gift from Dr. Julian Mercer (Deakin 
University, Australia) (27). The polyclonal antibody for SOD3 detection has been described 
previously (28). Other antibodies were obtained commercially, including anti-γ-adaptin (BD 
Biosciences, San Jose, CA), anti-V5 (Invitrogen, Carlsbad, CA), anti-SOD1 (BioDesign 
International, Kennebunk, ME), a biotin-conjugated goat anti-rabbit IgG, and anti-rabbit IgG 
(Bio-Rad Laboratories, Hercules, CA). C57BL/6J mice and ApoE−/− mice on a C57BL/6J 
background were obtained from the Jackson Laboratory (Bar Harbor, ME). The heterozygous 
blotchy MNK mutant mouse females and wild-type males were also obtained from Jackson 
Laboratory, used for establishing a colony, and maintained on regular chow. In the current study, 
male hemizygous mice carrying X-linked blotchy MNK mutation and control littermates were 
used. CHO cells stably expressing SOD3 were maintained as described previously (5). 
Experiments were performed with 1% serum with no additives. Transient transfection of human 
MNK cDNA in pWSK29 into CHO cells was performed using the PolyFect transfection reagent 
(Qiagen, Valencia, California) according to the manufacturer’s recommendations. 
Western blot analysis 
Western blot analysis was performed as described previously (28). The primary antibodies used 
included a rabbit polyclonal antibody against murine SOD3 (28), a sheep antibody against 
human SOD1, and rabbit polyclonal antisera to MNK. Equal loading of proteins was confirmed 
by Ponceau or Coomassie blue staining. 
SOD activity assays 
SOD activity was assayed by monitoring inhibition of the rate of xanthine/xanthine oxidase-
mediated reduction of cytochrome c as described previously (28). Con A-Sepharose 
chromatography (Amersham Biosciences, Piscataway, NJ) was used to isolate SOD3 from 
vessels of MNK mutant mice and their control littermates and the conditioned culture media of 
MNK mutant and wild-type cells as described previously (11, 28). 
Cu2+ affinity chromatography 
The Cu2+ affinity of SOD3 in the conditioned culture medium from MNK mutant and wild-type 
cells was assessed as previous described (29). Briefly, copper affinity column was prepared 
using a 1 ml HiTrap chelating column (Amersham Biosciences), and copper was coupled to the 
columns by applying 0.1 M CuCl2. Excess metal was then removed from each column using 
equilibrated buffer (20 mM Tris Cl and 0.5 M NaCl, pH 7.2). The sample was then loaded onto 
each copper-bound column, followed by washing thoroughly with equilibrated buffer. The 
copper binding proteins were eluted with increasing concentration of imidazole (0–100 mM) in 
the equilibrated buffer. All fractions were concentrated using Amicon Ultra-30 centrifugal filter 
devices (Millipore, Billerica, MA), and analyzed by Western blot analysis as described above. 
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Confocal immunofluorescence analysis 
For this analysis (30), we used cultured mouse fibroblasts on coverslips fixed in 4% 
paraformaldehyde, permeabilized in 0.1% Triton X-100, and incubated with chicken anti-MNK 
antibody (1:100) followed by incubation with FITC-conjugated goat antibodies to chicken IgG 
(1:100) (Santa Cruz Biotechnology, Santa Cruz, CA), and rabbit anti-SOD3 antibody (1:100), 
followed by incubation with rhodamine-conjugated goat antibodies to rabbit IgG (1:100) (Santa 
Cruz Biotechnology). In other experiments, cells were stained with a mouse monoclonal 
antibody against γ-adaptin (1:500; Santa Cruz Biotechnology), followed by a biotin-conjugated 
rabbit anti-murine IgG (1:200; Bio-Rad Laboratories). Cells were examined with a Bio-Rad 
MRC 1024 confocal microscope, using argon laser excitation lines of 488 and 514 nm with 
emission filters of 540/30 and 580/32 nm. 
Subcellular fractionation analysis 
Subcellular fractionation was performed as described previously (30–32). Briefly, following two 
rinses with ice-cold PBS, confluent cells were lysed in 50 mM Tris-HCl, pH 7.5, 5 mM MgCl2, 
25 mM KCl, 0.25 M sucrose, and a protease inhibitor cocktail (Roche Applied Science, 
Indianapolis, IN). Following lysis, cells were disrupted by 20 strokes with a tight-fitting glass 
Dounce homogenizer, and the postnuclear supernatants were isolated by centrifugation at 500 g 
for 5 min. This supernatant was then subjected to discontinuous sucrose density gradient 
fractionation as described previously (31, 32). A total of six fractions were collected from each 
gradient at the following sucrose interfaces: 0.9–1.1 M, 1.1–1.2 M, 1.2–1.3 M, 1.3–1.4 M, 1.4–
1.5 M, and 1.5–1.7 M. Fifty microliters of each fraction were used for Western analysis. 
Coimmunoprecipitation of SOD3 and MNK in stably transfected CHO cells and in mouse 
fibroblasts 
Coimmunoprecipitation was performed as described previously (5). 
In vitro pull down assays using recombinant SOD3 with V5-His tag in mouse fibroblasts 
Human recombinant SOD3 with V5-His tag was produced in a Drosophila expression system 
(Invitrogen) as reported previously (11). Mouse fibroblast cells were lysed with 500 µl of 50 
mmol/l Tris-HCl buffer containing 0.1 mmol/l EDTA, 0.1 mmol/l EGTA, 1% Triton X-100, and 
a protease inhibitor cocktail (Roche Applied Science). For in vitro pull down assays, one 
microgram of recombinant SOD3 protein was incubated with mouse fibroblast cell lysates (200 
μg) and 1 μg of anti-His-tag antibody (Cell Signaling Technology, Beverley, MA) overnight at 
4°C with constant rocking. The immunocomplexes were captured with 20 μl of protein A/G 
agarose beads (Santa Cruz Biotechnology) and incubated at 4°C for 1.5 h. Immunoprecipitates 
were separated using SDS-PAGE and transferred to nitrocellulose membranes, and 
immunoblotted with anti-MNK, anti-Na, K-ATPase, and anti-V5 antibody. 
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Measurements of vascular superoxide production in aortas from MNK mutant mice and 
control littermates 
Animals were killed by CO2 inhalation. The aortas were rapidly removed and placed into chilled 
modified Krebs/HEPES buffer (composition in mmol/l: NaCl 99.01, KCl 4.69, CaCl2 2.50, 
MgSO4 1.20, KH2PO4 1.03, NaHCO3 25.0, Na-HEPES 20.0, and glucose 5.6; pH 7.4), cleaned 
of excessive adventitial tissue, and cut into 4- to 5-mm ring segments with care taken not to 
injure the endothelium. Vascular O2•– production was determined using lucigenin-enhanced 
chemiluminescence as described previously. (33) This method has been validated for O2•– 
measurements in vascular tissue when low concentrations of lucigenin (5 µmol/l) are used (34). 
As a second approach to measure ROS production in vessels in situ, frozen cross-sections of 
aortas were stained with dihydroethidium (Molecular Probes, Eugene, OR) using a previously 
validated method (5). 
Immunohistochemical analysis 
Tissues were embedded in OCT (Miles Laboratories, Elkhart, IN) and frozen using liquid 
nitrogen. Cryosections were stained with either a rabbit polyclonal antibody against murine 
SOD3 (1:10,000) (28) or a rabbit polyclonal antibody against human MNK (1:100) (22), 
followed by a biotin-conjugated goat anti-rabbit IgG (1:100; Bio-Rad Laboratories). Staining 
was developed using the ABC-AP Kit (Vector Laboratories, Burlingame, CA). 
Statistical analysis 
All data are expressed as mean ± SE. Data were compared between groups of cells and animals 
by t test when one comparison was performed or by ANOVA for multiple comparisons. When 
significance was indicated by ANOVA, the Tukey-Kramer post hoc test was used to specify 
between group differences. Values of P < 0.05 were considered statistically significant. 
RESULTS 
Specific activity of SOD3 is decreased in cultured MNK mutant mouse fibroblasts 
 Although the tissue expression of MNK is known to be widespread, its expression in the 
vasculature is not available. As shown in Fig. 1, MNK was abundantly expressed in vascular 
smooth muscle cells, vascular endothelial cells, fibroblasts, and aorta as ~178 kDa protein that 
has been reported in other cells (30). 
To determine whether MNK is required for the full activity of SOD3, we used cultured brindled 
MNK mutant (MNKbr) mouse fibroblasts, which have a deletion of two conserved amino acids 
(Ala799 and Leu800) and an impairment of copper transport function (21–23). SOD3 from the 
conditioned media of control and MNK mutant cells was purified using concanavalin A 
sepharose chromatography as described previously (11). Activity of SOD3 in the culture medium 
was robustly decreased in MNK mutant fibroblasts as compared with control cells, while protein 
levels of SOD3 were increased (Fig. 2A, 2B). Thus, the specific activity of SOD3, as determined 
by the ratio of SOD3 activity to SOD3 protein, was markedly decreased in MNK mutant 
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fibroblasts (84.8±1.2% decrease, P<0.01) (Fig. 2C). In contrast, the activity, protein, and specific 
activity of SOD1 were not changed in MNK mutant fibroblasts (Fig. 2). 
The copper affinity of SOD3, as determined by copper affinity chromatography, was not 
changed in MNK mutant cells, suggesting that the decrease in SOD3-specific activity in MNK 
mutant cells is not due to a decrease in copper affinity of SOD3 (Fig. 3A). However, specific 
activity of SOD3 purified from MNK mutant cells was partially restored by addition of copper 
(Fig. 3B). Although specific activity of SOD3 purified from control cells was not affected by 
copper addition (Fig. 3B), it was decreased by the copper chelator BCS (bathocuproine 
disulfonate) (data not shown). These results suggest that most of the enzyme secreted from 
control cells is fully metallated. Thus, MNK is required for copper loading to SOD3 for its full 
activity. 
Colocalization of SOD3 and MNK in the trans-Golgi network 
Since we found that specific activity of SOD3 is dependent on MNK, we next examined where 
MNK delivers copper to SOD3 in the secretory pathway. Confocal immunofluorescence analysis 
showed that MNK and SOD3 partially colocalized with γ-adaptin, a trans-Golgi network resident 
protein, in the perinuclear region (Fig. 4A). Furthermore, subcellular fractionation analysis 
demonstrated that MNK and SOD3 partially cofractionated with γ-adaptin, but not GM130, a cis-
Golgi resident protein (Fig. 4B). These results suggest that SOD3 colocalizes with MNK in the 
trans-Golgi network of the secretory pathway. 
SOD3 directly interacts with MNK in a copper-dependent manner 
To determine how SOD3 obtains copper through MNK, we performed coimmunoprecipitation of 
SOD3 and MNK in mouse fibroblasts. As shown in Fig. 5A, SOD3 was coimmunoprecipitated 
with MNK, which was enhanced by addition of copper in a dose-dependent manner. In contrast, 
their association was inhibited by the copper chelator BCS. The interaction of SOD3 and MNK 
was further confirmed using CHO cells cotransfected with both proteins (Fig. 5B). In vitro pull 
down assays demonstrated that interaction of SOD3 with MNK is direct and specific, because 
recombinant SOD3 bound to MNK protein, but not to unrelated protein Na, K, ATPase (Fig. 
5C). These data suggest that MNK directly interacts with SOD3 in a copper-dependent manner. 
MNK is required for full activation of SOD3 in vascular tissue 
To confirm further that MNK is required for the full activity of SOD3 in vivo, we employed 
aortas from MNK mutant mice and control littermates. Since male brindled MNK mutant mice 
die at around 15 d after birth (19), we used male mice carrying the X-linked blotchy MNK 
mutation (MNKblo) which have splice site mutations with stop codon at amino acid residue 794 
with impaired copper transport function, but survive more than six months of age (19, 20, 25). 
Consistent with the results obtained with cultured fibroblasts from the brindled MNK mutant 
mice, activity of SOD3 was markedly decreased in aortas from the MNKblo mutant mice 
compared with those from control littermates, while protein levels of SOD3 were significantly 
increased (Fig. 6A, 6B). In contrast, the activity and protein of SOD1 were not altered in aortas 
from MNKblo mutant mice (Fig. 6A, 6B). Thus, the specific activity of SOD3, but not SOD1, was 
robustly decreased in aortas from MNKblo mutant mice (90±3.4% decrease, P<0.01) (Fig. 6C). 
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Taken together, these findings indicate that loss of MNK function markedly decreased the 
specific activity of SOD3, but not SOD1, in vascular tissue. 
Increased vascular O2•– production in MNK mutant mice 
To determine the functional significance of MNK in modulating SOD3 activity in vivo, we 
measured O2•– production in aortas from control and MNKblo mutant mice using lucigenin-
enhanced chemiluminescence. We found that vascular O2•– was markedly increased in aortas 
from MNK mutant mice as compared with those from control littermates (Fig. 7A). To estimate 
O2•- production in mouse aortas in situ, we also used the dihydroethidium (DHE) fluorescence 
method. DHE is a fluorescent dye that has been shown to specifically detect O2•– in situ (5, 35). 
DHE staining clearly demonstrated that O2•– production was markedly increased in all layers of 
aortas from MNK mutant mice (Fig. 7B). Importantly, the fluorescence signal was markedly 
decreased by the addition of SOD, suggesting that the DHE signal mainly reflects an increase in 
O2•–. Taken together, these findings suggest that MNK plays an important role in regulating 
vascular O2•– levels, at least in part, by modulating vascular SOD3 activity. 
MNK is highly expressed in the intimal lesions of atherosclerotic vessels 
To gain further insight into the role of MNK in modulating SOD3 activity in atherosclerosis in 
which SOD3 expression and O2•– production are markedly increased (28), we performed 
immunohistochemical analysis of MNK protein in aortas from control and ApoE−/− mice. Aortas 
from control mice showed a staining of MNK and SOD3 in the medial layer, while aortas from 
ApoE−/− mice demonstrated an intense staining of MNK protein in the intimal lesion of 
atherosclerosis with a concomitant increase in SOD3 in the extracellular matrix (Fig. 8). Note 
that MNK was highly expressed in the endothelium in atherosclerotic vessels from ApoE−/− 
mice. 
DISCUSSION 
MNK belongs to a large family of cation-transporting P-type ATPase, and plays a key role in 
transporting copper from the cytosol into the secretory pathways. Although MNK has been 
shown to be essential for full activity of some secretory copper enzymes such as tyrosinase and 
peptidylglycine α-amidating monooxygenase in mammalian cells (17, 18), little is known about 
its role in the vasculature. Here we provide the first evidence that MNK is highly expressed in 
the vascular tissues and cells, and that MNK is required for full activation of the secretory copper 
enzyme SOD3 using cultured fibroblasts and aortas from MNK mutant mice (19, 20, 22, 23). Of 
note, activation of the cytosolic copper enzyme SOD1 is MNK-independent. Copper affinity 
chromatography analysis showed that the decrease in SOD3-specific activity in MNK mutant 
cells is not due to the reduced copper affinity of SOD3. Specific activity of SOD3 purified from 
MNK mutant cells is partially restored by copper addition. These findings indicate that MNK 
plays a critical role in delivering copper to SOD3 for its full activation. However, SOD3 activity 
is not completely inhibited in MNK mutant cells, suggesting that MNK-independent copper 
delivery pathway for SOD3 may also exist. It is not clear why copper addition could not 
completely restore specific activity of SOD3 purified from MNK mutant cells. This might be due 
to the possibility that added copper is not incorporated properly into the active site of SOD3 in 
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MNK mutant cells. Consistent with our results, specific activity of other secretory copper 
enzyme such as peptidylglycine-α-hydroxylating monooxygenase (PHM) in MNK mutant cells 
is less than that in wild-type cells after addition of copper (23). 
SOD3 is a secretory copper enzyme containing a classical signal peptide that will direct SOD3 
from the endoplasmic reticulum through the trans-Golgi network to the plasma membrane, 
thereby being secreted into the extracellular space (37). Since we found that specific activity of 
SOD3 is dependent on MNK, we next investigated the mechanisms by which MNK delivers 
copper to SOD3 in the secretory pathway. Both immunofluorescence and subcellular fraction 
analysis revealed that SOD3 partially colocalizes with MNK and γ-adaptin, a marker of the trans-
Golgi network, suggesting that MNK transports copper to SOD3 in the trans-Golgi network. 
Moreover, coimmunoprecipitation and in vitro pull down assays demonstrated that MNK directly 
interacts with SOD3 in vivo and in vitro. Thus, these data suggest that MNK delivers copper to 
SOD3 in the trans-Golgi network through direct binding to SOD3. We also found that interaction 
of MNK with SOD3 is copper-dependent. To our knowledge, this is the first evidence that MNK 
directly interacts with its target secretory copper enzyme in a copper-dependent manner. The 
detailed mechanisms of how SOD3 obtains copper from MNK require further investigation. 
Since the level of intracellular free copper is extraordinarily restricted (12), MNK requires 
cytosolic copper carrier proteins to deliver copper to SOD3 in the trans-Golgi network (38). We 
have recently demonstrated that the copper chaperone Atox1 is involved in copper delivery to 
SOD3 (11). There are several proteins such as MNK, WND (ATP7B), and FKBP52 (39) that 
receive copper from Atox1; however, it has been shown that Atox1 delivers copper to other 
secretory copper-containing enzymes via MNK in the yeast system (40, 41). Thus, it is likely that 
SOD3 may obtain copper through Atox1-MNK pathway in the vascular cells. 
To determine the functional significance of MNK in modulating SOD3 activity in vivo, we 
measured O2•– levels in aortas from control and MNK mutant mice. Lucigenin 
chemiluminescence and SOD inhibitable DHE fluorescence assays demonstrated that vascular 
O2•– level was significantly increased in MNK mutant mice in which vascular SOD3 activity was 
markedly decreased. Neither hydroxyl radical, NO•, peroxynitrite, H2O2, hypochlorite, or singlet 
O2 significantly oxidizes HE (43). In addition, since SOD cannot enter the intracellular space, the 
detected SOD inhibitable DHE signal may mainly reflect the O2•– derived from extracellular 
space. Indeed, oxyethidium, a specific fluorescent product by the reaction of DHE and 
superoxide anion (42), is cell-permeable (unpublished observation). These results suggest that 
MNK plays an essential role in modulating O2•– through regulating SOD3 activity in the 
vasculature. 
NO• exerts myriads of biological effects, including dilation of vessels, inhibition of proliferation 
of vascular smooth muscle cells, and platelet aggregation (44). These properties are 
antiatherogenic and antihypertensive. Bioavailability of NO• can be regulated by extracellular 
O2•−, because NO• and O2•− undergo an extremely rapid, diffusion limited radical/radical 
reaction, leading to the formation of the potent oxidant peroxynitrite anion (44) that is involved 
in numerous pathophysiological processes (45). Endothelium-derived NO• must transverse the 
extracellular space between the endothelium and the smooth muscle to induce smooth muscle 
relaxation. Therefore, the increase in extracellular O2•− production, at least in part, due to 
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decrease in SOD3 activity in MNK mutant mice, may decrease the level of NO• in the vessel 
wall. Thus, MNK may play an important role in regulating available NO• to modulate vascular 
function. 
To gain insight into the role of MNK in modulating SOD3 activity in atherosclerosis in which 
SOD3 expression and O2•– production are markedly increased, we performed 
immunohistochemical analysis of MNK protein in atherosclerotic aorta from ApoE−/− mice. We 
found that MNK protein expression was highly expressed in the intimal lesion of atherosclerosis 
where SOD3 was markedly expressed in the extracellular matrix (Fig. 8). Of note, despite the 
specific activity of SOD3 is decreased in MNK mutant mice, the protein expression is rather 
increased in these mice (Fig. 1 and 5). We have previously shown that Atox1 functions not only 
as a copper chaperone but also as a positive regulator for SOD3 transcription (11). Atox1 is also 
markedly increased in the intimal lesion of atherosclerosis (11), and knockdown of Atox1 by 
siRNA completely abolishes the increase in SOD3 protein levels in MNK mutant cells 
(unpublished observation). Thus, these findings suggest that the increase in SOD3 protein levels 
in MNK mutant cells may be due to the up-regulation of Atox1. Note that some Menkes mutant 
mice, where SOD3 activity is markedly decreased, show vascular abnormalities including 
formation of aortic aneurysm (46), which is associated with oxidative stress (47, 48). Thus, it is 
conceivable that MNK also may be involved in aortic aneurysm formation by modulating 
vascular redox state via regulating SOD3 activity. Studies focused on the functional role of 
MNK and the mechanisms of how MNK regulates SOD3 expression in atherosclerosis and other 
cardiovascular diseases are subjects of further investigation. 
In summary, the present study demonstrates that MNK plays an essential role in regulating 
SOD3 activity through transporting copper to SOD3 in the trans-Golgi network, thereby 
modulating vascular O2•– levels. In the cardiovascular system, SOD3 is highly expressed in 
blood vessels and plays a major role in increasing nitric oxide bioactivity by scavenging 
extracellular O2•–. Thus, our study should provide a novel insight into how redox state of blood 
vessel is tightly controlled by copper transport systems. 
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Figure 1. Expression of MNK in the vasculature. Lysates from human fibroblasts, human aortic smooth muscle cells 
(HASM), human aortic endothelial cells (HAEC), human umbilical vein endothelial cells (HUVEC), and homogenates 
from mouse aorta were immunoblotted with anti-MNK antibody. Blots were representative of three experiments.   
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Figure 2. Activity (A), protein expression (B), and specific activity (C) of secreted SOD3 and SOD1 in cultured control 
(Contbr) and brindled MNK mutant (MNKbr) mouse fibroblasts (21–23). Cells were cultured in 1% serum containing 
DMEM for 72 h. The SOD3 secreted in the culture medium was collected and concentrated by concanavalin-A sepharose 
chromatography. A) Activity of SOD3 in concentrated culture medium and SOD1 in cell lysates was assayed by examining 
the inhibition of cytochrome c reduction by xanthine/xanthine oxidase at pH 7.4 (28). The results are presented as mean ± 
SE from 4 separate experiments. †P < 0.01 vs. control. NS, not significant. B) Protein levels of SOD1 and SOD3 were 
determined by Western analysis with antibodies specific to either the SOD1 or the SOD3. Representative blots are from 4 
individual experiments. C) Specific activity of SOD1 and SOD3 was determined by the ratio of activity to relative amount 
of protein as previously described (11). Equal protein loading was confirmed by Ponceau staining or Coomassie blue 
staining. The results are presented as mean ± SE from 4 separate experiments. †P < 0.01 vs. control. NS, not significant. 
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Figure 3. A) Copper binding affinity of SOD3 secreted from control (Contbr) and brindled MNK mutant (MNKbr) mouse 
fibroblasts (21–23). SOD3 protein in the conditioned medium was adsorbed to a Cu2+-affinity column and eluted with an 
imidazole gradient (0–100 mM) as previously described (29). The column was stripped with 50 mM EDTA, and all 
fractions, including the flow, were resolved by 15% acrylamide SDS/PAGE and assessed by SOD3 immunoblot analysis. 
B) The effect of in vitro copper treatment on SOD3-specific activity purified from Contbr and MNKbr mutant cells (21–23). 
Both cells were cultured in 1% serum containing DMEM for 72 h, and the cultured medium was harvested and 
concentrated as described in Fig. 1. The relative SOD3 protein content was determined as described in Fig. 1. After equal 
amounts of SOD3 protein were treated with or without CuCl2 (10 µM, 60 min, at room temperature), SOD3 activity was 
measured. Graph shows mean data for 3 separate experiments. *P < 0.05 vs. vehicle alone. NS, not significant. 
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Figure 4. A) Localization of MNK and SOD3 in mouse fibroblasts by confocal immunofluorescence analysis with 
antibodies to MNK (a, c), SOD3 (b, c), and γ-adaptin (a, b). Right panels) Merged image from each double-labeling 
(×400). The γ-adaptin was used as a marker for trans-Golgi network. B) Localization of MNK and SOD3 by subcellular 
fractionation analysis of mouse fibroblasts. Immunoblotting of lysates was performed following discontinuous sucrose 
density gradient fractionation. Fifty microliters from each fraction was separated by SDS-PAGE and immunoblotted with 
antibodies to MNK, SOD3, γ-adaptin, and GM130. The γ-adaptin and GM130 were used as markers for trans-Golgi 
network and cis-Golgi, respectively. 
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Figure 5. Coimmunoprecipitation of SOD3 and MNK in mouse fibroblasts (A) and CHO cells stably transfected with V5-
SOD3 (B). A) Mouse fibroblasts were incubated with CuCl2 (0, 10, and 100 µM) or with the copper chelator BCS 
(bathocuproine disulfonate) (0.1 and 1 µM) for 12 h. Equal amounts of lysates were immunoprecipitated (IP) with anti-
mouse SOD3 antibody followed by immunoblotting (IB) with the anti-MNK antibody. IgG was included as a negative 
control for the immunoprecipitation and as an indicator of loading condition. The results are presented as mean ± SE from 4 
separate experiments. †P < 0.01 vs. nontreated cells. *P < 0.05 vs. nontreated cells. B) Two days after transient transfection 
with MNK cDNA, the cell lysates in CHO cells expressing V5-tagged SOD3 were immunoprecipitated (IP) with the 
antibody as indicated followed by immunoblotting (IB) with the anti-MNK antibody and the anti-V5 antibody to detect 
SOD3. IgG was included as a negative control for the immunoprecipitation. C) In vitro pull-down assays using 
recombinant SOD3 with V5-His tag in mouse fibroblasts. Human recombinant SOD3 with V5-His tag was incubated with 
mouse fibroblast cell lysates, and the mixture was immunoprecipitated (IP) with anti-His antibody, followed by 
immunoblotting (IB) with anti-MNK, anti-Na, K-ATPase, and anti-V5 antibody. IgG was included as a negative control for 
the immunoprecipitation. Cell lysates were included as a positive control. 
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Figure 6. Activity (A), protein expression (B), and specific activity (C) of SOD3 and SOD1 in aortas from control 
littermates (Contblo) and blotchy MNK mutant (MNKblo) mice (19, 20, 25). Aortas were homogenized as previously 
described (28). The activity, protein expression, and specific activity of SOD1 and SOD3 were determined as described in 
Fig. 1. Aortas from four mice were combined for each experiment (n=3 for each data point). The results are presented as 
mean ± SE, and the values are expressed as units per milligram of total protein. †P < 0.01 vs. control. *P < 0.05 vs. control. 
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Figure 7. A) Vascular O2•– production in aortas from control littermates (Contblo) and blotchy MNK mutant (MNKblo) 
mice as determined with lucigenin-enhanced chemiluminescence (5 µmol/l; n=5). Fresh control and MNK mutant mouse 
aortas were incubated with or without PEG-SOD (500 U/ml) for 30 min before assay. †P < 0.01 vs. control mice. B) In situ 
detection of superoxide production with dihydroethidium (DHE) in aortas from Contblo and MNKblo mutant mice. Fresh-
frozen control and MNK mutant mouse aortas were incubated with DHE for 30 min (top panels). SOD (500 U/ml) applied 
topically to the sequential cut sections of control and MNK mutant mouse aortas during the 30-min incubation with DHE 
(bottom panels). SOD abolished the fluorescence, confirming specificity of the fluorescent signal for O2–. Data are 
representative of 3 separate experiments. e, endothelium; m, media; a, adventitia. 
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Figure 8. Immunohistochemical detection of SOD3 and MNK in control and ApoE–/– mouse aortas. Immunostaining was 
performed using an anti-SOD3 or MNK antibody followed by a biotin-conjugated goat anti-rabbit IgG. Immunoreactivity 
for SOD3 and MNK were prominent in the intimal lesion in ApoE–/– mice (lower panels, brown staining). Black arrows 
indicate intense staining for MNK in endothelium of atherosclerotic vessels. Images are representative of 3 separate 
experiments. Absence of staining when the primary antibody was omitted. 
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